• About Avalia
      • Executive
      • Advisors
      • Directors
      • Partners
    • Science
      • Innate and adaptive immunity
      • Immune modulators targeting the liver
      • Publications and Patents
    • Therapeutic Areas
      • Chronic hepatitis B
      • Malaria
      • Influenza
      • Virus-associated cancers
      • Solid tumors
      • Pipeline
    • News
    • Contact
    • Immunity Amplified
    • About Us
    • Science
    • Therapeutic Areas
    • News
    • Contact

Pro-agonists of natural killer T cells

Posted on June 19, 2018August 9, 2018 by Daniel

US 14/417,487

© 2020 Avalia Immunotherapies

Website by Wink Brand Design